Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871

Clinical trial NCT02971293 · COMPLETED

Trial details

NCT number: NCT02971293
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease COPD

Start date: 2016-12-15
Primary completion: 2017-08-18
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.